Hypopigmentation: Clinical Trials

5 trials for Hypopigmentation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 not yet recruiting. 5 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Not yet recruiting 5
Phase 12Not yet recruiting 2
Phase 32Not yet recruiting 2

Follow Hypopigmentation: new trials by email Literature Review of Hypopigmentation trials Research Report on Hypopigmentation

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mitochondrial Network Modulation Approach Using Hyperbaric Oxygen (HBO) Therapy and Nb-UVB for Treating Vitiligo
OXYGENE MEDICINAL LIQUIDE AIR PRODUCTS MEDICAL - Vitiligo Vulgaris
Phase 2 / Phase 3Not yet recruitingCentre Hospitalier Universitaire de Nice52026-09-012026-06-05
A Clinical Trial of Multiple Doses of GR2301 Injection Combined With Phototherapy in Trial Participants With Vitiligo
GR2301 injection, Placebo - Vitiligo
Phase 1 / Phase 2Not yet recruitingGenrix (Shanghai) Biopharmaceutical Co., Ltd.1162026-06-012026-06-15
Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo
Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes (hUC-MSC-Exos) Intravenous Infusion, Oral Prednisone, Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes (hUC-MSC-Exos) Local Injection - Vitiligo, Mesenchymal Stem Cells
Phase 1 / Phase 2Not yet recruitingXijing Hospital962026-04-012026-04-09
Comparative Efficacy of hUCMSC-Secretome Delivered Via Microneedling and Intradermal Microinjection as Adjuvant Therapy to NB-UVB in Nonsegmental Vitiligo: A Quasi-Experimental Study
NB-UVB combined with microneedling and topical 10% secretome, receives NB-UVB combined with intradermal secretome injection, NB-UVB alone - Vitiligo
Phase 2 / Phase 3Not yet recruitingYohanes Firmansyah, dr, MH, MM1502026-03-182026-04-03
0.005% Latanoprost Gel for Nonsegmental Vitiligo
0.005% latanoprost gel, 0.1% mometasone furoate cream - Vitiligo - Macular Depigmentation
Phase 2Not yet recruitingUniversitas Padjadjaran102025-07-012025-06-11

Narrower conditions

Vitiligo (5)

Broader conditions

Pigmentation Disorders (5)  ·  Skin Diseases (5)  ·  Skin and Connective Tissue Diseases (5)

Interventions

Infusions, Intravenous (1)  ·  Percutaneous Collagen Induction (1)  ·  Phototherapy (1)  ·  Prednisone (1)  ·  Secretome (1)

Sponsors

Centre Hospitalier Universitaire de Nice (1)  ·  Genrix (Shanghai) Biopharmaceutical Co., Ltd. (1)  ·  Universitas Padjadjaran (1)  ·  Xijing Hospital (1)  ·  Yohanes Firmansyah, dr, MH, MM (1)

Countries

Indonesia (2)  ·  China (1)  ·  France (1)

Top investigators

Michael Jansen Politan (1)  ·  Reiva F Dwiyana, MD, PhD (1)  ·  Sukmawati Tansil Tan (1)  ·  Thierry Passeron, PhD (1)  ·  Yohanes Firmansyah (1)  ·  Yong Cui, Ph.D (1)

Results publications

PMID 19627411, PMID 25545321, PMID 27329330, PMID 31758835